Role of gp91phox-containing NADPH oxidase in the deoxycorticosterone acetate-salt-induced hypertension

被引:27
作者
Fujii, Aya
Nakano, Daisuke
Katsuragi, Miyuki
Ohkita, Mamoru
Takaoka, Masanori
Ohno, Yukihiro
Matsumura, Yasuo
机构
[1] Osaka Univ Pharmaceut Sci, Dept Pharmacol, Takatsuki, Osaka 5691094, Japan
[2] Osaka Univ, Grad Sch Med, Dept Pharmacol, Suita, Osaka 5650871, Japan
关键词
NADPH oxidase; gp91phox; deoxycorticosterone acetate (DOCA)-salt hypertension; superoxide;
D O I
10.1016/j.ejphar.2006.09.039
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
NADPH oxidase plays an important role in vascular oxidative stress in hypertensive diseases. We evaluated whether NADPH oxidase-dependent superoxide (02) production is involved in the deoxycorticosterone acetate (DOCA)-salt-induced hypertension, using mice which are genetically deficient in gp91 phox, an NADPH oxidase subunit protein (gp91(-/-) mice). Two weeks after the DOCA-salt treatment, systolic blood pressure was significantly elevated in wild-type mice, but not in gp91(-/-) mice. After a 5-week treatment period, wild-type mice developed high blood pressure, with a systolic blood pressure of 127 +/- 3 mm Hg, compared with 107 +/- 4 mm Hg in gp91(-/-) mice. Aortic O-2(-) production in wild-type DOCA-salt-treated mice was significantly higher than that in wild-type sham mice, whereas there were no significant differences in aortic 02 production between gp91(-/-) DOCA-salt-treated and sham mice. These findings suggest that vascular O-2(-) overproduction via gp91 phox-containing NADPH oxidase is one of the crucial factors in the development of DOCA-salt-induced hypertension. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:131 / 134
页数:4
相关论文
共 24 条
[1]   Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology [J].
Bengtsson, SH ;
Gulluyan, LM ;
Dusting, GJ ;
Drummond, GR .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2003, 30 (11) :849-854
[2]   Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response [J].
Beswick, RA ;
Zhang, HF ;
Marable, D ;
Catravas, JD ;
Hill, WD ;
Webb, RC .
HYPERTENSION, 2001, 37 (02) :781-786
[3]   NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat [J].
Beswick, RA ;
Dorrance, AM ;
Leite, R ;
Webb, RC .
HYPERTENSION, 2001, 38 (05) :1107-1111
[4]   NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1 [J].
Elmarakby, AA ;
Loomis, ED ;
Pollock, JS ;
Pollock, DM .
HYPERTENSION, 2005, 45 (02) :283-287
[5]   A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall [J].
Görlach, A ;
Brandes, RP ;
Nguyen, K ;
Amidi, M ;
Dehghani, F ;
Busse, R .
CIRCULATION RESEARCH, 2000, 87 (01) :26-32
[6]   gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension [J].
Jung, O ;
Schreiber, JG ;
Geiger, H ;
Pedrazzini, T ;
Busse, R ;
Brandes, RP .
CIRCULATION, 2004, 109 (14) :1795-1801
[7]   Superoxide anion production is increased in a model of genetic hypertension - Role of the endothelium [J].
Kerr, S ;
Brosnan, MJ ;
McIntyre, M ;
Reid, JL ;
Dominiczak, AF ;
Hamilton, CA .
HYPERTENSION, 1999, 33 (06) :1353-1358
[8]   Reactive oxygen species in hypertension -: An update [J].
Lassègue, B ;
Griendling, KK .
AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (09) :852-860
[9]   Vascular NAD(P)H oxidases:: specific features, expression, and regulation [J].
Lassègue, B ;
Clempus, RE .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2003, 285 (02) :R277-R297
[10]   Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension [J].
Laursen, JB ;
Rajagopalan, S ;
Galis, Z ;
Tarpey, M ;
Freeman, BA ;
Harrison, DG .
CIRCULATION, 1997, 95 (03) :588-593